OncoVista Innovative Therapies, Inc. (OVIT)
OncoVista Innovative Therapies, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in San Antonio, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,356. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of -0.92 implies it has historically moved less than the broad market.
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate. The company was founded on January 8, 1999 and is headquartered in San Antonio, TX.
OncoVista Innovative Therapies, Inc. is most often compared with the following Healthcare names: